Heart rehab may also strengthen aging muscles

NCT ID NCT07197463

Not yet recruiting Disease control Sponsor: Qilu Hospital of Shandong University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special cardiac rehabilitation program can improve muscle strength and reduce inflammation in elderly patients with both heart disease and sarcopenia (age-related muscle loss). One hundred participants will either receive rehab plus standard care or standard care alone for three months. Researchers will measure grip strength and blood markers to see if the rehab helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Phase I cardiac rehabilitation (low-intensity resistance training, breathing training, bedside cycling)
What this could lead to: If it works, this could point toward a simple, drug-free way to improve muscle strength and reduce inflammation in elderly heart patients with muscle loss.
What could go wrong: This is a small, early-stage study in China, so results may not apply to other populations. The intervention is non-invasive, so risks are low, but the benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY DISEASE SARCOPENIA

More trials for these conditions

Other studies related to the condition(s) this trial covers.